Mao, Wenhui

Global health 2050: the path to halving premature death by mid-century

Jamison, D. T., Summers, L. H., Chang, A. Y., Karlsson, O., Mao, W., Norheim, O. F., Ogbuoji, O., Schäferhoff, M., Watkins, D., Adeyi, O., et al. (2024) · The Lancet

Global Health Care IssuesGlobal Health and Epidemiology

Cited by 125

It is not too late to achieve global covid-19 vaccine equity

Yamey, G., Garcia, P., Hassan, F., Mao, W., McDade, K. K., Pai, M., Saha, S., Schellekens, P., Taylor, A., & Udayakumar, K. (2022) · BMJ

Vaccine Coverage and HesitancySARS-CoV-2 and COVID-19 Research

Cited by 114

Ten-year impacts of China's rural health scheme: lessons for universal health coverage

Zhang, Y., Dong, D., Xu, L., Miao, Z., Mao, W., Sloan, F., & Tang, S. (2021) · BMJ Global Health

Healthcare Systems and ReformsHealthcare Policy and Management

Cited by 44

Achieving global mortality reduction targets and universal health coverage: the impact of COVID-19

Mao, W., Ogbuoji, O., Watkins, D., Bharali, I., Nsiah-Boateng, E., Diab, M. M., Dwomoh, D., Jamison, D. T., Kumar, P., Kennedy McDade, K., et al. (2021) · PLOS Medicine

Healthcare Systems and ReformsGlobal Maternal and Child Health

Cited by 18

Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries

Schäferhoff, M., Zimmerman, A., Diab, M. M., Mao, W., Chowdhary, V., Gill, D., Karanja, R., Madikizela, M., Ogbuoji, O., & Yamey, G. (2022) · The Lancet Global Health

Pharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of Life

Cited by 11

Have lower-income groups benefited more from increased government health insurance subsidies? Benefit incidence analysis in Ningxia, China

Hu, M., Mao, W., Xu, R., Chen, W., & Yip, W. (2022) · Health Policy and Planning

Healthcare Systems and ReformsHealthcare Policy and Management

Cited by 8